Free Trial

Veru (VERU) Competitors

Veru logo
$0.61 +0.01 (+2.32%)
Closing price 04:00 PM Eastern
Extended Trading
$0.62 +0.01 (+1.34%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VERU vs. NATR, MED, EL, IPAR, PBH, HLF, USNA, NUS, CAPR, and VREX

Should you be buying Veru stock or one of its competitors? The main competitors of Veru include Nature's Sunshine Products (NATR), Medifast (MED), Estee Lauder Companies (EL), Interparfums (IPAR), Prestige Consumer Healthcare (PBH), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Capricor Therapeutics (CAPR), and Varex Imaging (VREX).

Veru vs. Its Competitors

Veru (NASDAQ:VERU) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

In the previous week, Veru and Veru both had 1 articles in the media. Nature's Sunshine Products' average media sentiment score of 0.97 beat Veru's score of 0.66 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veru
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nature's Sunshine Products
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Nature's Sunshine Products has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veru$16.89M5.33-$37.80M-$0.24-2.56
Nature's Sunshine Products$454.36M0.60$7.70M$0.5327.70

Veru presently has a consensus price target of $4.00, suggesting a potential upside of 551.68%. Nature's Sunshine Products has a consensus price target of $18.33, suggesting a potential upside of 24.89%. Given Veru's higher probable upside, equities analysts clearly believe Veru is more favorable than Nature's Sunshine Products.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veru
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Nature's Sunshine Products
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Nature's Sunshine Products has a net margin of 2.22% compared to Veru's net margin of 0.00%. Nature's Sunshine Products' return on equity of 6.98% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
VeruN/A -128.51% -76.51%
Nature's Sunshine Products 2.22%6.98%4.63%

47.2% of Veru shares are held by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are held by institutional investors. 15.2% of Veru shares are held by insiders. Comparatively, 4.7% of Nature's Sunshine Products shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Veru has a beta of -0.75, indicating that its stock price is 175% less volatile than the S&P 500. Comparatively, Nature's Sunshine Products has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.

Summary

Nature's Sunshine Products beats Veru on 11 of the 14 factors compared between the two stocks.

Get Veru News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VERU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERU vs. The Competition

MetricVeruMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$87.94M$10.32B$5.57B$9.34B
Dividend YieldN/A2.05%3.80%4.06%
P/E Ratio-2.5616.3128.1019.86
Price / Sales5.3329.26441.4199.96
Price / CashN/A22.2635.8457.94
Price / Book2.793.618.265.67
Net Income-$37.80M$233.40M$3.24B$257.80M
7 Day Performance5.25%-3.35%0.51%1.07%
1 Month Performance5.77%4.19%7.99%11.31%
1 Year Performance-39.23%-17.80%28.68%17.01%

Veru Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERU
Veru
2.5168 of 5 stars
$0.61
+2.3%
$4.00
+551.7%
-42.3%$87.94M$16.89M-2.56230News Coverage
NATR
Nature's Sunshine Products
2.0682 of 5 stars
$15.79
+1.1%
$18.33
+16.1%
-5.7%$291.48M$454.36M29.79850Positive News
MED
Medifast
3.6845 of 5 stars
$14.32
-0.6%
$16.50
+15.3%
-29.2%$157.34M$543.45M-22.02870Positive News
EL
Estee Lauder Companies
4.093 of 5 stars
$89.64
-1.6%
$77.70
-13.3%
-14.5%$32.25B$15.61B-37.0462,000Trending News
Analyst Forecast
IPAR
Interparfums
4.1447 of 5 stars
$133.67
-1.4%
$162.00
+21.2%
+4.9%$4.29B$1.47B26.01530Positive News
PBH
Prestige Consumer Healthcare
3.9029 of 5 stars
$76.49
0.0%
$93.33
+22.0%
+4.6%$3.78B$1.14B17.83540Positive News
Analyst Revision
HLF
Herbalife
4.7192 of 5 stars
$9.69
-4.8%
$11.50
+18.7%
-20.1%$986.59M$4.95B3.548,600
USNA
USANA Health Sciences
4.507 of 5 stars
$32.51
-1.5%
$36.00
+10.7%
-33.7%$605.36M$854.50M17.861,700Upcoming Earnings
NUS
Nu Skin Enterprises
2.8524 of 5 stars
$8.67
-6.3%
$6.88
-20.7%
-23.1%$428.16M$1.68B-10.833,100
CAPR
Capricor Therapeutics
2.5427 of 5 stars
$7.39
-3.3%
$22.56
+205.2%
+49.6%$337.58M$22.27M-5.20101Trending News
Analyst Forecast
Analyst Revision
VREX
Varex Imaging
4.2966 of 5 stars
$7.93
-2.9%
$22.50
+183.7%
-48.2%$326.72M$811M-7.702,300

Related Companies and Tools


This page (NASDAQ:VERU) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners